logo
Select company
Select metric
-757.69%EBIT Margin
VS
Market
6
Sector
21
Industry
9
History
-
$ 0.53Close
$ 0.24 - $ 2.44 52-Week Range
Ticker Information

Ticker

PRPH

Company Name

PROPHASE LABS INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

PROPHASE LABS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PRPH - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -25.31M-757.69%$ 3.34M
3/31/2025$ -30M-656.84%$ 4.57M
12/31/2024$ -42.82M-632.48%$ 6.77M
9/30/2024$ -35.22M-276.18%$ 12.75M
6/30/2024$ -33.79M-188.04%$ 17.97M
3/31/2024$ -30.62M-106.63%$ 28.71M
12/31/2023$ -21.52M-48.5%$ 44.38M
9/30/2023$ -15.41M-24.58%$ 62.71M
6/30/2023$ -6.93M-8.82%$ 78.54M
3/31/2023$ 8.31M8.8%$ 94.42M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROPHASE LABS INC's latest trailing twelve months (TTM) EBIT % stands at -12.92%.
  • Over the past 5 years, PROPHASE LABS INC's average EBIT % has been -131.52%.
  • The median EBIT % for PROPHASE LABS INC during this period was -11.59%
  • PROPHASE LABS INC reached its highest EBIT % over the past 5 years at 26.46%.
  • The lowest EBIT % recorded by PROPHASE LABS INC in the same timeframe -757.69%

PROPHASE LABS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
BNBX : APPLIED DNA SCIENCES INC -399.87%INBS : INTELLIGENT BIO SOLUTIONS INC -271.56%TNON : TENON MEDICAL INC -429.45%TRAW : TRAWS PHARMA INC 3028.25%TXMD : THERAPEUTICSMD INC -20.44%LGVN : LONGEVERON INC -894.31%BOLT : BOLT BIOTHERAPEUTICS INC -1217.01%LPCN : LIPOCINE INC -107.1%CYCN : CYCLERION THERAPEUTICS INC -89.51%XAIR : BEYOND AIR INC -826.24%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for PROPHASE LABS INC is calculated as follows: EBIT [ $ -1.61M ] / Revenues [ $ 12.49M ]
(=) EBIT % [ -12.92% ]

PRPH - EBIT Margin, Last 5 years

-757.69%

Minimum

Jun 30, 2025

26.46%

Maximum

Sep 30, 2022

-131.52%

Average

-11.59%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%